Federal Circuit Affirms Summary Judgment of Non­Infringement for Particle Detector Patents

Jan 29, 2015

Reading Time : 1 min

TSI distinguished the accused products by asserting that claim six requires a system that converts a light detector’s output into a digital voltage signal without comparing the light detector’s output to a predetermined reference voltage. While claim six of the originally issued patent did not recite any language or negative limitations regarding a reference voltage, the patent was subject to a reexamination proceeding where claim six was modified to include the limitation: “without using a reference voltage to convert each voltage value signals.” That limitation is echoed by the patent’s specification, which distinguishes the technique of using a reference voltage as a problematic prior art method—since it results in an insufficient signal­to­noise ratio, thereby limiting the device’s sensitivity—that the patent was meant to overcome. Because the court found that TSI’s accused devices utilize a reference voltage in converting the light signals into a digital voltage signal, it affirmed the district court’s grant of summary judgment of non­infringement.

Notably, last year the CAFC affirmed a district court ruling that Lockheed Martin did not infringe the same patent asserted here against TSI. Also, remarkably, the CAFC’s opinion here cited to Cybor Corp. v. FAS Techs., Inc.,138 F.3d 1448, 1456 (Fed. Cir. 1998) (en banc) for the proposition that claim construction is a question of law that reviewed de novo – even though Cybor was overturned just last week by the United States Supreme Court in Teva v. Sandoz, No. 13­854, slip op. (U.S. Jan. 20, 2015), which holds that factual conclusions that underpin claim construction rulings are no longer reviewed de novo but rather for clear error (i.e., claim constructions are now to be given deference on appeal).

Yufa v. TSI, Inc., No. 2015­1063, slip op. (Fed. Cir. Jan. 26, 2015).

Share This Insight

Categories

Previous Entries

IP Newsflash

December 9, 2025

The Federal Circuit recently denied a petition for a writ of mandamus that challenged the PTO Director’s reliance on “settled expectations” to discretionarily deny two inter partes review (IPR) petitions. In so doing, the court explained that, while it was not deciding whether the Director’s use of “settled expectations” was correct, the petitioner’s arguments about what factors the Director may consider when deciding whether to institute an IPR or post-grant review (PGR) are not generally reviewable and did not provide sufficient basis for mandamus review here.

...

Read More

IP Newsflash

December 5, 2025

District courts are split on whether a complaint can provide the required knowledge for post-suit indirect and willful infringement in that same lawsuit. Chief Judge Connolly in the District of Delaware recently confirmed that, consistent with his prior opinions, the complaint cannot serve as the basis for knowledge for either a claim of post-suit indirect infringement or a demand for willfulness-based enhanced damages in that lawsuit.

...

Read More

IP Newsflash

December 3, 2025

The Federal Circuit recently held that a patentee acted as its own lexicographer to define a claim term even though it did not explicitly define the term. Rather, because the patentee consistently and clearly used two terms interchangeably to describe the same structural feature and did so in all of the embodiments in which the feature appeared, the patentee impliedly gave the term its own, unique definition.

...

Read More

IP Newsflash

December 2, 2025

The Federal Circuit recently held an asserted patent was not entitled to its priority date because the priority application lacked written description support for the asserted claims. In so doing, the court explained that broad disclosures that do not provide reasonably specific support for narrower claims do not meet the written description requirement. The court also considered whether the inventor’s testimony showed they possessed the full scope of the claimed genus at the priority date or whether it was more likely the inventors first became aware of the claimed embodiments from public disclosures of the accused product.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.